Tuesday, September 15, 2015 9:55:03 AM
The company is one of the nation’s leading drugstore chains, with nearly 4,600 stores in 31 states and the District of Columbia. Many on Wall Street see the company very favorably positioned in health care, given its geographic overlap with Medicaid expansion, as well as its push into clinics.
Shares were changing hands at the end of the week at $8.61. The consensus analyst price target is $10.05, and the stock has a 52-week trading range of $4.42 to $9.47.
Read more: Upcoming Earnings Reports Include Rite Aid, Oracle (NYSE: ORCL) (NYSE: RAD) - 24/7 Wall St. http://247wallst.com/investing/2015/09/13/top-4-earnings-for-the-week-ahead/#ixzz3loc4eNEy
Follow us: @247wallst on Twitter | 247wallst on Facebook
Recent RADCQ News
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 01/12/2024 10:00:11 PM
- Rite Aid Banned From Using AI Facial Recognition in FTC Settlement • Dow Jones News • 12/19/2023 10:57:00 PM
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • BLO • Apr 25, 2024 8:52 AM
Kona Gold Beverages, Inc. Announces Name Change to NuVibe, Inc. and Initiation of Ticker Symbol Application Process • KGKG • Apr 25, 2024 8:30 AM
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM